Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 28, 1998
Issued Date -
N/A
app pub date -
Jun 7, 1995
filing date -
Feb 1, 1988
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to novel T-cell epitopes of bacterial products. The epitopes of the invention may be employed in the preparation of conjugates between the epitopes and medically useful antigens, haptens, or antigenic determinants. These conjugates are capable of eliciting antibody responses similar to conjugates of antigens covalently coupled to carrier proteins, and in a vaccine composition, provide a safe and more economic conjugate vaccines.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully